BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27042848)

  • 1. How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCT.
    Fuji S; Rovó A; Ohashi K; Griffith M; Einsele H; Kapp M; Mohty M; Majhail NS; Engelhardt BG; Tichelli A; Savani BN
    Bone Marrow Transplant; 2016 Aug; 51(8):1041-9. PubMed ID: 27042848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New-Onset Post-Transplant Diabetes Mellitus after Allogeneic Hematopoietic Cell Transplant Is Initiated by Insulin Resistance, Not Immunosuppressive Medications.
    Engelhardt BG; Savani U; Jung DK; Powers AC; Jagasia M; Chen H; Winnick JJ; Tamboli RA; Crowe JE; Abumrad NN
    Biol Blood Marrow Transplant; 2019 Jun; 25(6):1225-1231. PubMed ID: 30738170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New-onset Post-transplant Diabetes and Therapy in Long-term Survivors After Allogeneic Hematopoietic Stem Cell Transplantation.
    Dalla Via V; Halter JP; Gerull S; Arranto C; Tichelli A; Heim D; Passweg JR; Medinger M; Cesana-Nigro N
    In Vivo; 2020; 34(6):3545-3549. PubMed ID: 33144466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretransplantation C-Peptide level predicts early posttransplantation diabetes mellitus and has an impact on survival after allogeneic stem cell transplantation.
    Griffith ML; Jagasia MH; Misfeldt AA; Chen H; Engelhardt BG; Kassim A; Savani BN; Survant M; Jagasia SM
    Biol Blood Marrow Transplant; 2011 Jan; 17(1):86-92. PubMed ID: 20561594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Complications Precede Alloreactivity and Are Characterized by Changes in Suppression of Tumorigenicity 2 Signaling.
    Johnpulle RA; Paczesny S; Jung DK; Daguindau E; Jagasia MH; Savani BN; Chinratanalab W; Cornell RF; Goodman S; Greer JP; Kassim AA; Sengsayadeth S; Byrne MT; Engelhardt BG
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):529-532. PubMed ID: 28013014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early post-transplant hyperglycemia and post-transplant diabetes mellitus following heart transplantation.
    Kuang W; Raven LM; Muir CA
    Expert Rev Endocrinol Metab; 2024 Mar; 19(2):129-140. PubMed ID: 38251642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of preexisting diabetes mellitus on transplantation outcomes in hematopoietic stem cell transplantation.
    Radfar M; Faghihi T; Hadjibabaie M; Ebrahimi F; Qorbani M; Iravani M; Ghavamzadeh A
    Endocr Res; 2015; 40(1):20-4. PubMed ID: 24833082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting posttransplantation diabetes mellitus by regulatory T-cell phenotype: implications for metabolic intervention to modulate alloreactivity.
    Engelhardt BG; Jagasia SM; Crowe JE; Griffith ML; Savani BN; Kassim AA; Lu P; Weitkamp JH; Moore DJ; Yoder SM; Rock MT; Jagasia M
    Blood; 2012 Mar; 119(10):2417-21. PubMed ID: 22262764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of selected endocrine complications in patients treated with auto- and allo-haematopoietic stem cell transplantation].
    Niedzielska E; Wójcik D; Barg E; Pietras W; Sega-Pondel D; Doroszko A; Niedzielska M; Skarzyńska M; Chybicka A
    Med Wieku Rozwoj; 2008; 12(3):761-6. PubMed ID: 19305027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic Nutritional Support in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
    Fuji S; Einsele H; Savani BN; Kapp M
    Biol Blood Marrow Transplant; 2015 Oct; 21(10):1707-13. PubMed ID: 26172477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic hematopoietic stem cell transplant recipients and parasitic diseases: A review of the literature of clinical cases and perspectives to screen and follow-up active and latent chronic infections.
    Fabiani S; Fortunato S; Petrini M; Bruschi F
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28128496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life, social challenges, and psychosocial support for long-term survivors after allogeneic hematopoietic stem-cell transplantation.
    Norkin M; Hsu JW; Wingard JR
    Semin Hematol; 2012 Jan; 49(1):104-9. PubMed ID: 22221790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early clinical assessment of glucose metabolism in renal allograft recipients: diagnosis and prediction of post-transplant diabetes mellitus (PTDM).
    Kuypers DR; Claes K; Bammens B; Evenepoel P; Vanrenterghem Y
    Nephrol Dial Transplant; 2008 Jun; 23(6):2033-42. PubMed ID: 18174264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperglycemia as a possible risk factor for mold infections-the potential preventative role of intensified glucose control in allogeneic hematopoietic stem cell transplantation.
    Fuji S; Löffler J; Savani BN; Einsele H; Kapp M
    Bone Marrow Transplant; 2017 May; 52(5):657-662. PubMed ID: 27941771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postprandial blood glucose level in maintenance hemodialysis patients predicts post-transplant-diabetes-mellitus.
    Haider DG; Mittermayer F; Friedl A; Batrice A; Auinger M; Wolzt M; Hörl WH
    Exp Clin Endocrinol Diabetes; 2010 Mar; 118(3):200-4. PubMed ID: 20072964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
    Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progress of research on allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimen for treatment of myelodysplastic syndrome - review].
    Zhang Z; Li X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):969-74. PubMed ID: 18718102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central Nervous System Involvement at the Time of Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with a Poor Outcome in Patients with Acute Myeloid Leukemia.
    Ikegawa S; Doki N; Kaito S; Kurosawa S; Sakaguchi M; Harada K; Yamamoto K; Hino Y; Shingai N; Senoo Y; Watanabe D; Hagino T; Yoshioka K; Watakabe K; Igarashi A; Najima Y; Kobayashi T; Kakihana K; Sakamaki H; Ohashi K
    Pathol Oncol Res; 2017 Apr; 23(2):433-437. PubMed ID: 28004352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart failure after allogeneic hematopoietic stem cell transplantation.
    Mo XD; Xu LP; Liu DH; Zhang XH; Chen H; Chen YH; Han W; Wang Y; Wang FR; Wang JZ; Zhao T; Yan CH; Sun YQ; Liu KY; Huang XJ
    Int J Cardiol; 2013 Sep; 167(6):2502-6. PubMed ID: 22727962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical analysis of acute renal failure after allogeneic hematopoietic stem cell transplantation].
    Zhou T; Cen XN; Qiu ZX; Ou JP; Wang WS; Xu WL; Li Y; Wang MJ; Wang LH; Tong YJ; Ren HY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):723-8. PubMed ID: 19549395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.